Jubilant Life Sciences’ US subsidiary - Jubilant Cadista Pharmaceuticals Inc. has received approvals from the U.S. Food and Drug Administration (US FDA) for Escitalopram Tablets USP, 5mg, 10mg and 20mg, Olanzapine Orally Disintegrating Tablet 5mg, 10mg, 15 mg and 20mg, Losartan Potassium Tablets USP, 25 mg, 50mg and 100 mg and Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg.
Escitalopram is used for acute treatment of generalized anxiety disorder and acute and maintenance treatment of major depressive disorders with its branded version LEXAPRO enjoying a market size of about $ 2.7 Billion.
Olanzapine ODT is a bioequivalent generic version of ZYPREXA ZYDIS Orally Disintegrating Tablets indicated for the treatment of schizophrenia and for the short term treatment of acute manic or mixed episodes associated with Bipolar I disorder.
Losartan Potassium is a potent, highly specific angiotensin receptor blocker (ARB).It is desirable for an effective treatment of hypertension and also lowers the chance of stroke in patients with high blood pressure and heart problem called left ventricular hypertrophy.
Losartan Potassium and Hydrochlorothiazide Tablets is a combination of ARB and a diuretic. Annual sales for the branded drug HYZAAR is approximately $ 670 Million. Jubilant has already launched generic versions of both in Europe and the two filings are awaiting approval in few other markets.
Escitalopram and Olanzapine ODT would be manufactured in Jubilant’s dosage formulations facility at Roorkee, India. Losartan Potassium and its variant would be manufactured at the facility in Maryland,USA.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1823.00 |
| Dr. Reddys Lab | 1351.00 |
| Cipla | 1487.65 |
| Lupin | 2185.00 |
| Zydus Lifesciences | 978.00 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
